Hyderabad: Advanced Enzyme Technologies will acquire a 70 per cent stake in JC Biotech, a city-based maker of active pharma ingredients (APIs), for Rs 50 crore.
Advanced Enzyme, a leading speciality biotech company which manufactures enzymes, on Friday said it has entered into definitive agreements with JC Biotech for the stake buy.
The company said in a statement that the proposed transaction was approved by its board on Friday.
"We expect this deal to immediately strengthen our market leadership in API Serratiopeptidase, giving us significant competitive advantage as well as flexibility in production," Advanced Enzymes managing director C L Rathi said.
"JC Biotech has the ability to handle solvent-based fermentation & recovery, which is highly complementary to our current production process."
JC Biotech is the maker of API Serratiopeptidase, an anti-inflammatory enzyme, and has a research and development pipeline of biopharma molecules.
It also has a fairly advanced technology for the manufacturing of algal DHA, an Omega 3 Fatty Acid which finds great application in Human Nutrition, the statement said.
As on March 31, 2016, JC Biotech's revenues stood at Rs 39 crores with a profit after tax (PAT) of Rs 2.5 crore. The acquisition is expected to close latest by the end of December. Advanced Enzymes will finance the acquisition largely through internal accruals, the statement added.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
